Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07276581 · ClinicalTrials.gov registry record · Phase 2

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

A Phase 2 study of Rheumatoid Arthritis, sponsored by AstraZeneca.

Recruiting
Registry status
Phase 2
Development phase
320
Enrollment target
20
Study locations

NCT07276581 is a Phase 2 study of Rheumatoid Arthritis that is actively recruiting participants, run by AstraZeneca. The registered enrollment target is 320 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (93% lower). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07276581, a Phase 2 study of Rheumatoid Arthritis, is actively recruiting participants, sponsored by AstraZeneca.

RECRUITING
Registry status
Phase 2
Development phase
320 participants
Enrollment target
20
Study locations

Study Summary

Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.

Conditions Studied

Rheumatoid Arthritis

Interventions

  • OTHER Placebo
  • DRUG AZD1163

Study Locations (20)

Texas

  • Research Site - Austin
  • Research Site - Baytown
  • Research Site - Houston
  • Research Site - Houston
  • Research Site - Mesquite
  • Research Site - Tomball

Florida

  • Research Site - Boynton Beach
  • Research Site - Jacksonville
  • Research Site - South Miami
  • Research Site - Tampa

Arizona

  • Research Site - Glendale
  • Research Site - Prescott Valley

California

  • Research Site - La Jolla
  • Research Site - San Dimas

Illinois

  • Research Site - Willowbrook

Louisiana

  • Research Site - Lake Charles

Maryland

  • Research Site - Baltimore

Massachusetts

  • Research Site - New Bedford

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2025-12-15
Est. Completion 2028-08-18
Phase Phase 2

Sponsor

AstraZeneca

1,285 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07276581

The ClinicalTrials.gov registry entry for NCT07276581 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (93% lower). The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT07276581 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Texas, Florida, Arizona.

Frequently Asked Questions

What is clinical trial NCT07276581 about?

NCT07276581 is a clinical study titled "A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis". Phase II study in participants with moderately-to-severely active rheumatoid Arthritis (RA) to evaluate efficacy and safety of AZD1163.

What is the current status of trial NCT07276581?

This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 320 participants. The study started on 2025-12-15. Estimated completion is 2028-08-18.

What conditions does trial NCT07276581 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT07276581?

The interventions under investigation include: Placebo (OTHER), AZD1163 (DRUG).

Who is sponsoring clinical trial NCT07276581?

This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07276581 being conducted?

This trial has 20 study locations across Arizona, California, Florida, Illinois, Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.